Table 4.
Structural proteins of AngHV-1 as identified by 1D gel and 2D nanoLC-MS/MS
| ORFa | NCBI ID | Locationb | Descriptionc | Predicted molecular mass (kDa) | 1D gel/nanoLC-MS/MSd | 2D nanoLC-MS/MSe | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number of peptides | Mascot score | EmPAI | Number of peptides | Mascot score | EmPAI | |||||
| 8 | 282174045 | Envelope | Membrane protein type 1 | 21.2 | 29 | 1138 | 1.3 | 37 | 1339 | 2.59 |
| 14 | 282174051 | Tegument | ORF3 family | 32.3 | - | - | - | - | - | - |
| 16 | 282174053 | Tegument-associated | ORF13 family | 33.8 | 12 | 349 | 0.88 | 11 | 465 | 0.66 |
| 17 | 282174054 | Tegument-associated | ORF13 family | 25.8 | 21 | 1010 | 0.51 | 10 | 459 | 0.70 |
| 18 | 282174055 | Tegument | 233.6 | - | - | - | - | - | - | |
| 19 | 282174056 | Tegument | 93.7 | 5 | 179 | 0.17 | 13 | 713 | 0.30 | |
| 20 | 282174057 | Tegument | 63.1 | 3 | 123 | 0.19 | - | - | - | |
| 24 | 282174061 | Tegument-associated | ORF13 family | 29.3 | 11 | 493 | 1.07 | 11 | 471 | 0.59 |
| 26 | 282174063 | Tegument-associated | 18.4 | - | - | - | - | - | - | |
| 30 | 282174067 | Tegument-associated | 118.4 | 23 | 801 | 0.54 | 16 | 450 | 0.34 | |
| 32 | 282174069 | Tegument-associated | 20.0 | 5 | 239 | 1.41 | - | - | - | |
| 34 | 282174071 | Tegument-associated | 195.0 | 71 | 2641 | 1.32 | 58 | 2200 | 0.71 | |
| 35 | 282174072 | Tegument-associated | 33.4 | 19 | 797 | 1.35 | 18 | 632 | 0.67 | |
| 36 | 282174073 | Capsid | Capsid triplex protein 2 | 40.2 | 29 | 1016 | 3.99 | 22 | 856 | 1.80 |
| 38 | 282174075 | Tegument | 44.1 | 4 | 142 | 0.39 | - | - | - | |
| 39 | 282174076 | Tegument | 62.7 | 2 | 57 | 0.12 | - | - | - | |
| 40 | 282174077 | Tegument | 162.7 | 22 | 783 | 0.56 | 13 | 446 | 0.29 | |
| 42 | 282174079 | Capsid | Capsid triplex protein 1 | 42.9 | 20 | 979 | 1.73 | 17 | 558 | 1.42 |
| 43 | 282174080 | Tegument-associated | 18.0 | 4 | 121 | 0.48 | 8 | 291 | 1.12 | |
| 48 | 282174085 | Capsid | 102.6 | 32 | 1112 | 1.18 | 26 | 876 | 0.97 | |
| 49 | 282174086 | Envelopef | Membrane protein type 3 | 26.4 | 1 | 38 | 0.14 | 1 | 42 | 0.14 |
| 51 | 282174088 | Envelope | Major envelope protein/Membrane protein type 3 | 26.5 | 30 | 1042 | 4.70 | 30 | 972 | 2.18 |
| 57 | 282174094 | Capsid | Capsid protease-and-scaffolding protein | 78.0 | 9 | 345 | 0.45 | 8 | 328 | 0.43 |
| 66 | 282174103 | Envelope | Membrane protein type 1 | 42.7 | 6 | 458 | 0.18 | - | - | - |
| 67 | 282174104 | Envelope | WBV spike protein/Major glycoprotein/Membrane protein type 1 | 152.9 | 25 | 948 | 0.43 | 15 | 577 | 0.26 |
| 71 | 282174108 | Envelope | Membrane protein type 1 | 11.4 | 4 | 172 | 0.82 | 3 | 103 | 0.33 |
| 78 | 282174115 | Envelope | Membrane protein type 3 | 16.9 | 4 | 146 | 0.23 | - | - | - |
| 81 | 282174118 | Tegument-associated | 51.5 | 7 | 226 | 0.63 | 1 | 56 | 0.07 | |
| 83 | 282174120 | Tegument-associated | Cysteine protease domain/Large tegument protein | 376.8 | 166 | 6652 | 1.46 | 104 | 3870 | 0.71 |
| 95 | 282174132 | Envelope | ISAV HA/Membrane protein type 1 | 41.6 | 54 | 2069 | 1.81 | 52 | 2256 | 1.48 |
| 100 | 282174137 | Capsid | 61.1 | 2 | 66 | 0.13 | 1 | 33 | 0.03 | |
| 103 | 282174140 | Tegument | - | - | - | - | - | - | ||
| 104 | 282174141 | Capsid | Major capsid protein | 139.9 | 213 | 8402 | 5.33 | 104 | 4058 | 2.56 |
| 108 | 282174145 | Envelope | ORF80 family | 108.2 | - | - | - | 1 | 33 | 0.06 |
| 114 | 282174151 | Tegument-associated | 20.7 | 28 | 852 | 3.64 | 13 | 550 | 1.27 | |
| 115 | 282174152 | Envelope | - | - | - | - | - | - | ||
| 125 | 282174162 | Envelope | ORF109 family | - | - | - | - | - | - | |
| 126 | 282174163 | Capsid | 22.4 | 1 | 30 | 0.17 | - | - | - | |
| 128 | 282174165 | Tegument-associated | 17.9 | 4 | 139 | 0.48 | 1 | 60 | 0.21 | |
| 129 | 282174166 | Tegument-associated | 42.2 | 8 | 290 | 0.19 | 6 | 238 | 0.18 | |
athe ORF are ordered by number with the ORF only detected in the virion fractions presented in italics, blocation as determined in this paper, cproperties newly suggested in this paper are presented in italics, dnumber of peptides, Mascot score and emPAI in the complete virion fraction as determined by 1D gel/nanoLC-MS/MS, enumber of peptides, Mascot score and emPAI in the complete virion fraction as determined by 2D nanoLC-MS/MS, fAngHV-1 ORF49 was not detected in the envelope fraction and classified as an envelope protein only on the basis of predicted structural properties.